OncoSil Medical Limited (ASX:OSL)

Australia · Delayed Price · Currency is AUD

0.9700

-0.0050 (-0.51%)

Sep 17, 2026, 4:10 PM AEST

OncoSil Medical Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	5.09	5.09	1.54	1.57	1.47	1.06
Revenue Growth	36.62%	231.48%	-1.92%	6.68%	38.00%	-18.09%
Gross Profit	2.73	2.73	-0.72	0.06	-0.12	0.09
Operating Income	-11.01	-11.01	-15.09	-11.98	-11.34	-10.58
Net Income	-10.86	-10.86	-15.1	-11.91	-11.34	-10.73
Earnings Per Share	-0.48	-0.48	-1.38	-2.16	-4.02	-5.29
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Australia	0.09	0.09	0.02	0.06	-
Europe	1.4	1.4	0.87	0.46	0.11
Middle East	0.19	0.19	0.29	-	-
Total	1.68	1.68	1.17	0.52	0.37

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	6.48	6.48	5.11	4.5	9.39	11.28
Total Debt	0.01	0.01	0.07	0.07	0.17	0.3
Net Cash (Debt)	6.46	6.46	5.04	4.43	9.22	10.98
Net Cash Growth	129.76%	28.20%	13.75%	-51.96%	-15.97%	-6.63%
Net Cash Per Share	0.29	0.29	0.46	0.80	3.27	5.41

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-10.47	-10.47	-12.06	-10.82	-11.32	-10.11
Capital Expenditures	-0	-0	-0.01	-0.2	-0.06	-0.01
Free Cash Flow	-10.47	-10.47	-12.08	-11.02	-11.37	-10.12
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	53.68%	53.68%	-46.79%	3.55%	-8.27%	8.55%
Operating Margin	-216.41%	-216.41%	-982.80%	-765.58%	-772.48%	-994.72%
Pretax Margin	-213.40%	-213.40%	-983.53%	-761.07%	-772.98%	-1008.73%
Profit Margin	-213.40%	-213.40%	-983.53%	-761.07%	-772.98%	-1008.73%
FCF Margin	-205.81%	-205.81%	-786.66%	-704.07%	-775.06%	-951.30%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 17, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Forward PE	-	6.53	6.53	6.53	6.53	6.53
PS Ratio	7.00	4.31	11.12	8.51	16.16	37.28